Officer John Cox proposes selling 5,513 Dyne Therapeutics (DYN) shares around November 13, 2026.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
John Cox, an officer at Dyne Therapeutics (DYN), has filed a Form 144 notice proposing to sell 5,513 common shares, valued at approximately $92,751.00, with an anticipated sale date of November 13, 2026. This proposed sale follows a previous sale of 5,658 common shares on September 8, 2026, which yielded gross proceeds of Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context